Trial Profile
Effects of angiotensin receptor blocker, Candesartan on renal function in type 2 diabetes with chronic kidney disease and hypertension
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 13 May 2016
Price :
$35
*
At a glance
- Drugs Candesartan cilexetil (Primary)
- Indications Hypertension; Renal failure; Type 2 diabetes mellitus
- Focus Therapeutic Use
- 13 May 2016 New trial record